{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T18:36:03Z","timestamp":1762540563383},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,2,7]],"date-time":"2014-02-07T00:00:00Z","timestamp":1391731200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1471-2261-14-16","type":"journal-article","created":{"date-parts":[[2014,2,7]],"date-time":"2014-02-07T20:02:10Z","timestamp":1391803330000},"source":"Crossref","is-referenced-by-count":10,"title":["Aspirin use and knowledge in the community: a population- and health facility based survey for measuring local health system performance"],"prefix":"10.1186","volume":"14","author":[{"given":"Gregory A","family":"Roth","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine W","family":"Gillespie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali A","family":"Mokdad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danny D","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David W","family":"Fleming","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andy","family":"Stergachis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher JL","family":"Murray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali H","family":"Mokdad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,2,7]]},"reference":[{"key":"672_CR1","doi-asserted-by":"publisher","first-page":"e27","DOI":"10.1056\/NEJMp1110421","volume":"365","author":"TR Frieden","year":"2011","unstructured":"Frieden TR, Berwick DM: The \u201cmillion hearts\u201d initiative \u2014 preventing heart attacks and strokes. N Engl J Med. 2011, 365: e27-10.1056\/NEJMp1110421.","journal-title":"N Engl J Med"},{"key":"672_CR2","doi-asserted-by":"publisher","first-page":"396","DOI":"10.7326\/0003-4819-150-6-200903170-00008","volume":"150","author":"From the U.S. Preventive Services Task Force, Agency for Healthcare Research and Quality, Rockville, Maryland","year":"2009","unstructured":"From the U.S. Preventive Services Task Force, Agency for Healthcare Research and Quality, Rockville, Maryland: Aspirin for the prevention of cardiovascular disease: U.S. preventive services task force recommendation statement. Ann Intern Med. 2009, 150: 396-404.","journal-title":"Ann Intern Med"},{"key":"672_CR3","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/S0002-8703(96)90173-8","volume":"131","author":"E Shahar","year":"1996","unstructured":"Shahar E, Folsom AR, Romm FJ, Bisgard KM, Metcalf PA, Crum L, McGovern PG, Hutchinson RG, Heiss G: Patterns of aspirin use in middle-aged adults: the atherosclerosis risk in communities (ARIC) study. Am Heart J. 1996, 131: 915-922. 10.1016\/S0002-8703(96)90173-8.","journal-title":"Am Heart J"},{"key":"672_CR4","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.amjcard.2009.10.014","volume":"105","author":"CP Cannon","year":"2010","unstructured":"Cannon CP, Rhee KE, Califf RM, Boden WE, Hirsch AT, Alberts MJ, Cable G, Shao M, Ohman EM, Steg PG, Eagle KA, Bhatt DL: Current use of aspirin and antithrombotic agents in the United States among outpatients with atherothrombotic disease (from the REduction of Atherothrombosis for Continued Health [REACH] registry). Am J Cardiol. 2010, 105: 445-452. 10.1016\/j.amjcard.2009.10.014.","journal-title":"Am J Cardiol"},{"key":"672_CR5","unstructured":"STATISTICAL BRIEF #179: aspirin use among the adult U.S. Noninstitutionalized population, with and without indicators of heart disease, 2005. \n                    http:\/\/meps.ahrq.gov\/mepsweb\/data_files\/publications\/st179\/stat179.shtml\n                    \n                  ,"},{"key":"672_CR6","unstructured":"U.S. Census Bureau: generated by Greg Roth using State & county quickfacts. King County, WA, \n                    http:\/\/factfinder2.census.gov\n                    \n                  ,"},{"key":"672_CR7","unstructured":"Stata statistical software: release 12. 2011, College Station, TX: StataCorp LP"},{"key":"672_CR8","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1161\/01.CIR.97.18.1837","volume":"97","author":"PW Wilson","year":"1998","unstructured":"Wilson PW, D\u2019Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB: Prediction of coronary heart disease using risk factor categories. Circulation. 1998, 97: 1837-1847. 10.1161\/01.CIR.97.18.1837.","journal-title":"Circulation"},{"key":"672_CR9","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/0378-4347(84)80099-7","volume":"310","author":"RJ O\u2019kruk","year":"1984","unstructured":"O\u2019kruk RJ, Adams MA, Philp RB: Rapid and sensitive determination of acetylsalicylic acid and its metabolites using reversed-phase high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl. 1984, 310: 343-352.","journal-title":"J Chromatogr B Biomed Sci Appl"},{"key":"672_CR10","unstructured":"AGGRENOX (aspirin\/extended-release dipyridamole) capsules package insert. 2014, Ingelheim, Germany: Boehringer Ingelheim Pharmaceuticals, Inc"},{"key":"672_CR11","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1136\/jcp.51.7.502","volume":"51","author":"JR Paterson","year":"1998","unstructured":"Paterson JR, Blacklock C, Campbell G, Wiles D, Lawrence JR: The identification of salicylates as normal constituents of serum: a link between diet and health?. J Clin Pathol. 1998, 51: 502-505. 10.1136\/jcp.51.7.502.","journal-title":"J Clin Pathol"},{"key":"672_CR12","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1136\/jcp.54.7.553","volume":"54","author":"CJ Blacklock","year":"2001","unstructured":"Blacklock CJ, Lawrence JR, Wiles D, Malcolm EA, Gibson IH, Kelly CJ, Paterson JR: Salicylic acid in the serum of subjects Not taking aspirin. Comparison of salicylic acid concentrations in the serum of vegetarians, Non-vegetarians, and patients taking Low dose aspirin. J Clin Pathol. 2001, 54: 553-555. 10.1136\/jcp.54.7.553.","journal-title":"J Clin Pathol"},{"key":"672_CR13","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.ypmed.2008.05.009","volume":"47","author":"SP Glasser","year":"2008","unstructured":"Glasser SP, Cushman M, Prineas R, Kleindorfer D, Prince V, You Z, Howard VJ, Howard G: Does differential prophylactic aspirin use contribute to racial and geographic disparities in stroke and coronary heart disease (CHD)?. Prev Med. 2008, 47: 161-166. 10.1016\/j.ypmed.2008.05.009.","journal-title":"Prev Med"},{"key":"672_CR14","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1016\/S0140-6736(09)60503-1","volume":"373","author":"C Baigent","year":"2009","unstructured":"Baigent C, Blackwell L, Collins R, Emberson J, Godwin J, Peto R, et al: Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet. 2009, 373: 1849-1860.","journal-title":"Lancet"},{"key":"672_CR15","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1001\/archinternmed.2011.626","volume":"172","author":"S Mora","year":"2012","unstructured":"Mora S: Aspirin therapy in primary prevention\u2009<\u2009subtitle\u2009>\u2009comment on \u201ceffect of aspirin on vascular and nonvascular outcomes\u201d. Arch Intern Med. 2012, 172: 217-10.1001\/archinternmed.2011.626.","journal-title":"Arch Intern Med"},{"key":"672_CR16","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1001\/archinternmed.2011.628","volume":"172","author":"SRK Seshasai","year":"2012","unstructured":"Seshasai SRK: Effect of aspirin on vascular and nonvascular outcomes\u2009<\u2009subtitle\u2009>\u2009meta-analysis of randomized controlled trials. Arch Intern Med. 2012, 172: 209-10.1001\/archinternmed.2011.628.","journal-title":"Arch Intern Med"},{"key":"672_CR17","doi-asserted-by":"publisher","first-page":"JC6","DOI":"10.7326\/0003-4819-156-12-201206190-02003","volume":"156","author":"CM Rembold","year":"2012","unstructured":"Rembold CM: ACP journal club. Review: aspirin does not reduce CHD or cancer mortality but increases bleeding. Ann Intern Med. 2012, 156: JC6-3.","journal-title":"Ann Intern Med"},{"key":"672_CR18","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1093\/eurheartj\/ehs092","volume":"33","author":"J Perk","year":"2012","unstructured":"Perk J, De Backer G, Gohlke H, Graham I, Reiner Z, Verschuren M, Albus C, Benlian P, Boysen G, Cifkova R, Deaton C, Ebrahim S, Fisher M, Germano G, Hobbs R, Hoes A, Karadeniz S, Mezzani A, Prescott E, Ryden L, Scherer M, Syvanne M, Scholte Op Reimer WJM, Vrints C, Wood D, Zamorano JL, Zannad F, Cooney MT, Authors\/Task Force Members, et al: European guidelines on cardiovascular disease prevention in clinical practice (version 2012): the fifth joint task force of the European society of cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts) * developed with the special contribution of the European association for cardiovascular prevention & rehabilitation (EACPR). Eur Heart J. 2012, 33: 1635-1701.","journal-title":"Eur Heart J"},{"key":"672_CR19","doi-asserted-by":"publisher","first-page":"2694","DOI":"10.1161\/CIR.0b013e3181e3b133","volume":"121","author":"M Pignone","year":"2010","unstructured":"Pignone M, Alberts MJ, Colwell JA, Cushman M, Inzucchi SE, Mukherjee D, Rosenson RS, Williams CD, Wilson PW, Kirkman MS: Aspirin for primary prevention of cardiovascular events in people with diabetes: a position statement of the American diabetes association, a scientific statement of the American heart association, and an expert consensus document of the American college of cardiology foundation. Circulation. 2010, 121: 2694-2701. 10.1161\/CIR.0b013e3181e3b133.","journal-title":"Circulation"},{"key":"672_CR20","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1001\/jama.295.2.180","volume":"295","author":"DLSP Bhatt","year":"2006","unstructured":"Bhatt DLSP: INternational prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA. 2006, 295: 180-189. 10.1001\/jama.295.2.180.","journal-title":"JAMA"},{"key":"672_CR21","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1093\/annonc\/mds113","volume":"23","author":"C Bosetti","year":"2012","unstructured":"Bosetti C, Rosato V, Gallus S, Cuzick J, La Vecchia C: Aspirin and cancer risk: a quantitative review to 2011. Ann Oncol. 2012, 23: 1403-1415. 10.1093\/annonc\/mds113.","journal-title":"Ann Oncol"},{"key":"672_CR22","doi-asserted-by":"publisher","first-page":"197","DOI":"10.2337\/diacare.24.2.197","volume":"24","author":"DB Rolka","year":"2001","unstructured":"Rolka DB, Fagot-Campagna A, Narayan KMV: Aspirin use among adults with diabetes estimates from the third national health and nutrition examination survey. Dia Care. 2001, 24: 197-201. 10.2337\/diacare.24.2.197.","journal-title":"Dia Care"},{"key":"672_CR23","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1001\/archfami.5.5.297","volume":"5","author":"KD Burney","year":"1996","unstructured":"Burney KD, Krishnan K, Ruffin MT, Zhang D, Brenner DE: Adherence to single daily dose of aspirin in a chemoprevention trial. An evaluation of self-report and microelectronic monitoring. Arch Fam Med. 1996, 5: 297-10.1001\/archfami.5.5.297.","journal-title":"Arch Fam Med"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2261-14-16\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2261-14-16.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2261-14-16","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2261-14-16.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T20:44:48Z","timestamp":1548189888000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/1471-2261-14-16"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2,7]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["672"],"URL":"https:\/\/doi.org\/10.1186\/1471-2261-14-16","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,7]]},"article-number":"16"}}